Please login to the form below

Not currently logged in
Email:
Password:

Everyday Health appoints PHCG president

Michael du Toit to take up same position
Michael du Toit

Digital health and wellness company Everyday Health has named Michael du Toit as its president.

Du Toit has more than 30 years of experience in healthcare and consumer media and marketing and joins from Publicis Healthcare Communications Group (PHCG), where he served as global group president.

He has previously held executive roles at marketing agencies such as Digitas Health, where he was a founding member, Razorfish Health, Grey Advertising and Ventiv Health Communications.

Du Toit has additionally held senior marketing positions at pharma companies including GlaxoSmithKline and Boehringer Ingelheim.

Commenting on his appointment, du Toit said: “I am honoured to join Everyday Health and believe it has a unique set of capabilities and assets to win in the marketplace.

“I see great opportunities across the dynamic digital health landscape to further expand Everyday Health's consumer and professional business and I am very excited to get started.”

In the newly created role, du Toit will be responsible for managing and directing the strategy for the consumer and professional business including product, editorial, sales and sales development.

He will also be expected to guide Everyday Health's strategic direction and growth and ensure the company's growth in the market.

Ben Wolin, CEO and co-founder of Everyday Health, added: “We are thrilled to have Michael join our team as president and we are very confident his strong background, passion and experience make him perfectly suited to lead the continued growth of our consumer and healthcare professional businesses.”

18th February 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics